What Amplifon does

Amplifon S.p.A. is a Milan-headquartered, publicly-listed (Euronext Milan: AMP:IM, FTSE MIB constituent) global retailer of hearing care solutions, serving individuals with hearing loss in 26 countries through a network of approximately 10,000 points of sale and more than 8,800 audiologists. The group operates a multi-brand portfolio including Amplifon, Miracle-Ear, GAES, Beltone, Bay Audio, Beter Horen and Minisom, distributing its own Ampli-mini and Ampli-power hearing-aid product lines alongside third-party devices, with revenue evenly split between hearing-aid sales and lifecycle audiological services (fitting, adjustments, lifetime aftercare).

Underlying the retail operation is a proprietary technology stack centered on the Amplifon 360 protocol (a patented seven-step clinical journey from diagnosis to continuous follow-up), the OtoPad and OtoKiosk tablet-based audiometers (the only iPad-based audiometers with FDA Registration, CE Mark, ISO 13485, NOAH compatibility and HIPAA compliance), and the Amplifon App (deployed in 17 countries, rated 4.6 iOS and 4.5 Android) which provides device control, remote assistance, and the Companion AI function for predictive battery and program suggestions. In April 2026 Amplifon launched AmplifAI, an enterprise-wide AI governance, catalog and API-gateway platform that scales AI across operations, complemented by Salesforce Agentforce for Health pilots in managed care administration.

The commercial model combines B2C direct retail (corporate shops and shop-in-shop locations embedded in pharmacies, optical chains, and clinics), a Miracle-Ear franchise network of approximately 1,210 locations plus 400 directly-operated shops in the US, a managed care channel (Amplifon Hearing Health Care) providing hearing benefits to US health plan members, and a growing digital channel through the Amplifon App. Pricing is not publicly disclosed and varies by market, product tier and insurance coverage, with government reimbursement and consumer credit available in many countries. FY2025 revenue was €2.4 billion (1.7% growth at constant FX, 22.6% adjusted EBITDA margin) on a workforce of more than 20,000; the pending €2.3 billion acquisition of GN Hearing (announced March 2026, close end-2026) will add manufacturing capability, 700+ R&D professionals and 2,800+ patents, lifting pro-forma revenue to €3.3 billion across 100+ countries.

Name

Amplifon

Legal name

Amplifon S.p.A.

Website

https://corporate.amplifon.com

Company type

Public

Founded year

1950

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Amplifon is a Milan-headquartered global retailer of hearing care, operating ~10,000 points of sale across 26 countries with 8,800 audiologists, distributing proprietary and third-party hearing aids alongside clinical services, audiometry technology (OtoPad), an AI-powered Amplifon App, and an enterprise AmplifAI governance platform.

Ownership category

akta.pro rank

Product category

Hearing Care Retail

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Other Health Practitioners (6213), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Household Audio & Video Equipment (3651)

akta.pro primary industry

Hearing Enhancement / Assistive Listening Audio Devices (CRACANAL)

akta.pro secondary industries

Audiology & Hearing Services (ENT-Affiliated) (HLAKAMAI), Audiology & Hearing Diagnostic Centers (HLAFAKAH)

Keywords

• Hearing care retail
• Audiology services
• Hearing aid devices
• Hearing diagnostics
• Hearing health benefits

Headquarters

HQ city

Milan

HQ country

Italy

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Retail Hearing Aid Sales: Sale of hearing aids and related devices through owned retail locations, franchise network, and shop-in-shop locations. Revenue from sale of Amplifon product line and third-party hearing aid brands.
2. Hearing Care Services: Professional hearing care services including hearing tests, fittings, adjustments, and ongoing support. Revenue from professional audiological services delivered through network of 10,000 hearing centers.
3. Managed Care Services: Hearing benefit solutions provided to health plan members through Amplifon Hearing Health Care. Revenue from contracts with health insurance providers.
4. Franchise Revenue: Revenue from Miracle-Ear franchise network including technology distribution, brand licensing, training services, and marketing support to franchisees.

Go-to-market motion4 records

Distribution channels5 records

Marketing channels5 records

Core offering

Amplifon is a global hearing care retailer that sells branded hearing aids (Ampli-mini and Ampli-power product families) and delivers professional audiological services (hearing tests, fittings, adjustments, fine-tuning, and lifetime after-sale support) through a network of approximately 10,000 hearing centers across more than 25 countries. The company combines proprietary audiological protocols (Amplifon 360), proprietary digital tools (Amplifon App, OtoPad, OtoKiosk), and a multi-brand portfolio (Miracle-Ear, GAES, Beltone, ReSound, Bay Audio) to deliver personalized hearing care.

Product overview

Amplifon is a global hearing care retail company offering hearing aids and audiology services through a multi-brand portfolio. The company operates primarily as a hearing care retailer offering hearing products and services via an integrated platform approach. The core product portfolio includes proprietary digital tools (Amplifon App, OtoPad, OtoKiosk, Amplifon360 protocol) alongside the Amplifon product line of hearing aids (Ampli-mini, Ampli-power). The company also offers AmplifAI, a governance platform for scaling AI across operations. Amplifon's services are delivered through regional sub-brands including Miracle-Ear and Amplifon Hearing Health Care (Americas), GAES and Beter Horen (EMEA), and Bay Audio, Attune Hearing, and Bay Audiology (APAC). The Amplifon Product Experience platform integrates the hearing aid portfolio with the multichannel ecosystem, while AmplifonX serves as the digital innovation division developing new solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Ampli-mini: Product family including devices with highly discreet design, advanced technology, excellent performance and integrated artificial intelligence.
• Ampli-power
• Amplifon App
• Companion
• AmplifAI
• Ampli-care
• OtoPad
• OtoKiosk
• Amplifon 360

Products and services

• Ampli-mini hearing aid product family Hearing aid product family featuring highly discreet design, advanced technology, excellent performance, and integrated artificial intelligence for personalized hearing experience
• Ampli-power hearing aid product family Hearing aid product family delivering rich sound, top performance, long battery life, and all-day comfort for users with significant hearing needs
• Amplifon App Mobile application serving as the first touchpoint of the Amplifon hearing care ecosystem, allowing users to control hearing device functions in real-time, book appointments, access remote assistance, and receive AI-powered predictive maintenance suggestions through the Companion function; compatible with products from five hearing aid manufacturers
• OtoPad iPad-based audiometer First and only iPad-based audiometer (ANSI/ISO compliant, NOAH compatible, HIPAA compliant, FDA Registered, CE Mark) enabling 65% time savings on complete hearing test batteries
• OtoKiosk portable screening tool Portable hearing pre-screening tool derived from OtoPad, usable anywhere - in stores, medical practices, pharmacies, shopping malls or events - to increase productivity and hearing care awareness
• Miracle-Ear franchise program Miracle-Ear nationwide US hearing solution franchising program distributing branded technology and services through approximately 1,210 franchised locations and 400 direct shops under the Miracle-Ear brand
• Amplifon Hearing Health Care (Managed Care services) Independent provider of hearing benefit solutions working with US health plans to provide high-quality, affordable hearing care insurance and benefits to health plan members through a broad provider network
• Amplifon e-health Platform Digital health platform connecting hearing care specialists with customers for virtual appointments and remote hearing aid fine-tuning, building behavioral and purchase trend maps for personalized service
• Amplifon 360 hearing assessment protocol Proprietary hearing assessment protocol integrating pioneering methods and instruments across a seven-step journey from identifying needs to follow-up and continuous support, including tonal audiometry and word recognition tests in quiet and noisy environments
• GAES retail hearing care (Spain, Portugal, Latin America) Hearing care retail brand operating primarily in Spain, Portugal, and Latin America with approximately 600 points of sale, acquired in 2018 as the largest privately-owned specialty hearing care retailer worldwide
• Beter Horen retail hearing care (Netherlands) Dutch hearing care brand operating hearing retail centers in the Netherlands as part of Amplifon's European network
• Bay Audiology retail hearing care (New Zealand) New Zealand hearing care brand operating hearing retail centers as part of Amplifon's APAC regional network

Quantifiable outcome

• 13% global retail hearing care market share
• +4 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability11 records

Feature7 records

Partnerships

Five partnerships are on record, tiered supporting and core.

• Target ReplysupportingTechnology or Integration · 12 May 2026Target Reply implemented a data governance platform for Amplifon to optimize end-to-end visibility across its data ecosystem and reduce operational complexity. Supports data governance and integration initiatives.
• Dr. Nicholas ReedsupportingStrategic or Co-development Partner · 31 March 2026Dr. Nicholas Reed appointed as Vice President of Audiology Innovation and Research. Previously affiliated with Johns Hopkins University and NYU Grossman School of Medicine. Will oversee research initiatives and bring expertise linking hearing loss to broader health outcomes.
• GN Store Nord A/ScoreStrategic or Co-development Partner · 16 March 2026Amplifon signed definitive agreement to acquire GN Hearing from GN Store Nord for approximately €2.3 billion on cash-free and debt-free basis. Transaction comprises €1.69 billion in cash plus 56 million Amplifon shares. GN becomes second-largest shareholder with approximately 16% stake. Expected to close end of 2026. Creates vertically integrated global leader in audiology with combined revenues of €3.3 billion across 100+ countries.
• White & Case LLPsupportingImplementation/ SI/ Consulting Partner · 16 March 2026White & Case LLP advised Amplifon on €1.8 billion financing package to support acquisition of GN Hearing. Financing intended to fund cash component with subsequent refinancing through debt and equity instruments.
• SalesforcesupportingTechnology or Integration · 28 February 2025Amplifon is using or piloting Salesforce Agentforce for Health technology, which provides pre-built AI agent skills designed for healthcare organizations to automate administrative tasks including benefits verification and clinical support.

Scale indicators19 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Lexie Hearing: Lexie Hearing is an emerging DTC hearing aid brand in the US market offering affordable hearing aids with remote support. It targets the same mass-market consumer segment as Amplifon but through a lower-cost, direct-to-consumer model.
• Eargo: Eargo is a US direct-to-consumer hearing aid company selling virtually invisible, rechargeable hearing aids online. It represents the emerging DTC/OTC channel that could disrupt Amplifon's traditional clinic-based retail model.

Regional players

• MED-EL: MED-EL is an Austrian-based implantable hearing solutions company operating primarily in EMEA and select global markets. It addresses an adjacent clinical segment (cochlear and middle ear implants) that overlaps with Amplifon's audiology care pathway.

Broad incumbents

• Cochlear Limited: Cochlear is the global leader in implantable hearing solutions (cochlear implants, bone conduction). It addresses a related but distinct segment from Amplifon's retail hearing aid focus, representing an adjacent clinical specialty in hearing healthcare.
• GN Store Nord: GN Store Nord is the parent company of GN Hearing (ReSound, Beltone, Jabra) and is selling GN Hearing to Amplifon. Post-deal, GN becomes Amplifon's second-largest shareholder with ~16% stake, and remains a key supplier and strategic partner in the vertically integrated audiology value chain.

Direct peers

• WS Audiology: WS Audiology (formed from Widex and Sivantos/Signia) is a global hearing aid manufacturer combining the Widex and Signia brands. It directly competes with Amplifon in hearing aid devices and increasingly in retail audiology services.
• Demant: Demant is a Danish hearing healthcare company behind brands like Oticon, Bernafon, and Sonic, with both device manufacturing and retail operations. It is one of Amplifon's closest competitors globally in both retail hearing care and hearing aid technology.
• Sonova: Sonova is a leading global hearing care company offering hearing instruments (Phonak, Unitron) and cochlear implants (Advanced Bionics). It competes directly with Amplifon across hearing aids, audiology services, and retail distribution, and is one of the largest vertically integrated players in the industry.
• Starkey Hearing Technologies: Starkey is a US-based privately held hearing aid manufacturer with significant retail and wholesale operations. It competes directly with Amplifon in hearing devices, audiology services, and US retail distribution through its own branded network.

Others

• EssilorLuxottica: EssilorLuxottica is the global leader in eyewear and optical retail. While focused on vision rather than hearing, it represents a potential adjacent retail/optical model and competitor for shop-in-shop real estate and consumer healthcare retail spend.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCQ5kJDPqaBPbdEDKTZpAw8w
• LinkedInlinkedin.com/company/amplifon
• Instagraminstagram.com/amplifonofficial
• Xx.com/amplifon
• Facebookfacebook.com/AmplifonGroupCareers

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries14 records

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amplifon